Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors

Liver Transplantation

Volumn 14, Issue 3, 2008, Pages 365-373

  Mangus, Richard S ^a   Fridell, Jonathon A ^a   Vianna, Rodrigo M ^a   Milgrom, Martin A ^a   Chestovich, Paul ^a   Chihara, Ray K ^a   Tector, A Joseph ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APROTININ; ASPARTATE AMINOTRANSFERASE; HTK SOLUTION; LIVER ENZYME; METHYLPREDNISOLONE SODIUM SUCCINATE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; AGED; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIARY TRACT DISEASE; CADAVER; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG DOSE REDUCTION; ENZYME ANALYSIS; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LIVER FUNCTION; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; ORGAN DONOR; ORGAN PRESERVATION; OUTCOMES RESEARCH; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE;

ADENOSINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALLOPURINOL; ASPARTATE AMINOTRANSFERASES; CHILD; FEMALE; GLUCOSE; GLUTATHIONE; GRAFT SURVIVAL; HUMANS; INSULIN; KAPLAN-MEIERS ESTIMATE; LIVER; LIVER TRANSPLANTATION; MALE; MANNITOL; MIDDLE AGED; ORGAN PRESERVATION SOLUTIONS; PATIENT SELECTION; POTASSIUM CHLORIDE; PROCAINE; PROSPECTIVE STUDIES; RAFFINOSE; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 41149113398     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21372     Document Type: Article

References (18)

1. Englesbe MJ, Heidt D, Sung R, Pietroski R. Does using HTK solution for cold perfusion of cadaveric kidneys save money? Transplantation 2006;81:1750-1752.
2. Agarwal A, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006;81:480-482.
3. Agarwal A, Goggins WC, Pescovitz MD, Milgrom ML, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Transplant Proc 2005;37:2016-2019.
4. de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999;12:447-453.
5. Fridell JA, Agarwal A, Milgrom ML, Goggins WC, Murdock P, Pescovitz MD. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004;77:1304-1306.
6. Agarwal A, Murdock P, Pescovitz MD, Goggins WC, Milgrom ML, Fridell JA. Follow-up experience using histidine-tryptophan ketoglutarate solution in clinical pancreas transplantation. Transplant Proc 2005;37:3523-3526.
7. Potdar S, Malek S, Eghtesad B, Shapiro R, Basu A, Patel K, et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004;18:661-665.
8. Englesbe MJ, Moyer A, Kim DY, Granger DK, Pietroski R, Yoshida A, et al. Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: a multicenter study. Transplantation 2006;82:136-139.
9. Mangus RS, Tector AJ, Agarwal A, Vianna R, Murdock P, Fridell JA. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl 2006;12: 226-230.
10. Erhard J, Lange R, Scherer R, Kox WJ, Bretschneider HJ, Gebhard MM, et al. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study. Transpl Int 1994;7:177-181.
11. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980;28:295-302.
12. Hatano E, Kiuchi T, Tanaka A, Shinohara H, Kitai T, Satoh S, et al. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation. Clin Sci (Lond) 1997;93:81-88.
13. Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg 2003; 88:145-151.
14. Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl 2004;10:1415-1421.
15. Testa G, Malago M, Nadalin S, Treptow B, Paul A, Frilling A, et al. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study. Liver Transpl 2003;9:822-826.
16. Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006;244:439-450.
17. Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? Hepatology 2006;45: 484-488.
18. Eghtesad B, Aucejo F, Fung JJ. Preservation solutions in liver transplantation: what are the options. Liver Transpl 2006;12:196-198.